Buyback of Class B shares in Essity during week 5, 2025
The share purchase is part of the
The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation.
Class B shares in Essity were repurchased as follows:
Date | Aggregated daily volume (no. of shares): | Weighted average price per day (SEK): | Total daily transaction value (SEK): |
54,000 | 280.8596 | 15,166,418 | |
54,000 | 282.6415 | 15,262,641 | |
54,000 | 281.6179 | 15,207,367 | |
54,000 | 282.6927 | 15,265,406 | |
54,000 | 283.1783 | 15,291,628 | |
Total accumulated during week 5, 2025 | 270,000 | 282.1980 | 76,193,460 |
Total accumulated during the buyback program | 8,532,000 | 299.3272 | 2,553,859,649 |
All purchases were conducted on Nasdaq
For further information, please contact:
Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, [email protected]
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/essity/r/buyback-of-class-b-shares-in-essity-during-week-5--2025,c4099486
The following files are available for download:
Buyback of Class B shares in Essity during week 5, 2025 |
View original content:https://www.prnewswire.com/news-releases/buyback-of-class-b-shares-in-essity-during-week-5-2025-302366328.html
SOURCE Essity
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2026 CSCCP-ASCCP Colposcopy Training Course--Wuhan Station Concludes, Promoting More Precise and Non-Invasive Management of Cervical Lesions
- AS Tallinna Vesi will hold an Investor Conference Webinar to introduce the results for the 3rd quarter of 2026
- SATO Corporation Interim Report 1 January–30 September 2026: Occupancy rate increased due to strong operational performance
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Dividend, Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share